Farmacia Hospitalaria y Farmacogenómica

Sarmiento, E; Montanchez, J; Ezzahouri, I; Cifrian, J; Ortiz-Bautista, C; Laporta, R; Bravo, C; Salcedo, M; Rodriguez-Ferrero, ML; Gonzalez-Costello, J; Segovia, J; De Pablos, A; Mora, V; Ussetti, P; Lopez, S; Sabe, N; Gomez-Bueno, M; Sousa, I; Navas, P; Diez-Villanueva, P; Aguilar, M; Fernandez-Yunquera, A; Anaya, F; Muñoz, P; Valerio, M; Mur, A; Alarcon, A; Limay, K; Lopez-Hoyos, M; Lopez, F; Vionnet, A; Serrano, M; Carbone, J.

Evaluation of IVIG for Prevention of Infections Occurring On-study and Treatment of Infection of Solid Organ Recipients With Secondary Antibody Deficiency: A Phase 2 Randomized Clinical Trial

Transplantation Direct. 2026; 12(4): [doi:10.1097/TXD.0000000000001928]

Rodríguez-García, M; Salvador-Martín, S; Piedra, MSR; Bravo, A; Vidal, M; Gutierrez, CF; Maurel, J; López-Fernández, LA; Brunet, M.

Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive DPYD Pharmacogenetic Testing

Pharmaceuticals. 2026; 19(3): [doi:10.3390/ph19030460]

García-Díaz, HC; Gómez-Alonso, J; Rabuñal-Alvarez, MT; Ochagavía, M; Revuelta-Herrero, JL; González-Gómez, A; Riestra, AC; Oliver-Noguera, A; García, MM; Farriols, A; Macarulla, T; Carreras, MJ; Larrosa-Garcia, M.

Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitals

JOURNAL OF CHEMOTHERAPY. 2026; : [doi:10.1080/1120009X.2026.2639277]

Valdeolmillos Carbó LV; Esteban Gómez MJ; Ruiz-Jarabo Gómez I; Ribed Sánchez A; Vicente Oliveros N; Guisado Gil AB; Campino Villegas A; Campillos P; Olier Martínez P; de Pourcq JT.

Guidelines on the perioperative management of chronic medication in surgical patients.

FARMACIA HOSPITALARIA. 2026; 50(2): 115-119 [doi:10.1016/j.farma.2025.11.002]

Valdeolmillos Carbó LV; Esteban Gómez MJ; Ruiz-Jarabo Gómez I; Ribed Sánchez A; Vicente Oliveros N; Guisado Gil AB; Campino Villegas A; Campillos P; Olier Martínez P; de Pourcq JT.

Guidelines on the perioperative management of chronic medication in surgical patients.

FARMACIA HOSPITALARIA. 2026; 50(2): 115-119 [doi:10.1016/j.farma.2025.07.002]

Torroba-Sanz, B; de Lorenzo-Pinto, A; Gimenez-Manzorro, A; Redondo-Galan, C; Gomez-Costas, D; Benedí, J; Herranz-Alonso, A; Sanjurjo-Saez, M.

PharmaCenter: Impact of post-discharge pharmaceutical carea consultation on medication-related problems in the emergenc department: A comprehensive analysis

Research in Social & Administrative Pharmacy. 2026; 22(2): 311-316 [doi:10.1016/j.sapharm.2025.10.010]

Pizarro-Gómez, C; Collado-Borrell, R; Escudero-Vilaplana, V; Massarrah, T; Revuelta-Herrero, JL; Calles, A; Alvarez, R; Villanueva-Bueno, C; Mur-Mur, A; Sánchez-Fresneda, MN; Herranz, A; Benedí-González, J; Martín, M; Sanjurjo, M.

Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing

JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2026; : [doi:10.1177/10781552251409387]

Tato-Moreno, P; Olleros, CL; Martín, HB; Guerrero, MB; Mensa-Vilaro, A; Durán-García, ME; Sánchez-Mateos, P; García-Martínez, E.

Exploring targeted therapy in retinal vasculopathy with cerebral leukoencephalopathy: a case report and review of literature

Frontiers in Immunology. 2026; 16: 1707532-1707532 [doi:10.3389/fimmu.2025.1707532]

Taladriz-Sender, I; Salvador-Martin, S; Zapata-Cobo, P; López-Fernández, LA; Sanjurjo-Sáez, M; Garcia-González, X.

Update on pharmacogenetics in pediatrics

ANALES DE PEDIATRIA. 2026; 104(1): Nº de citas: 1 [doi:10.1016/j.anpedi.2025.503936]

Salgado-Cámara, P; De la Casa-Fages, B; Sánchez-Soblechero, A; Sierra, OM; Martín-Barbero, ML; Grandas, F.

Impact of a perioperative protocol for Parkinson's disease patients on use of contraindicated drugs

NEUROLOGIA. 2026; 41(1): [doi:10.1016/j.nrl.2023.11.011]

Ramos, JR; Peláez, MG; Clemente, YC; Requejo, CC; Alcón, EV; Mora, JRR; Blanch, CT; Palomares, AG; Costas, DG.

Adverse events associated with the use of flumazenil in the Emergency Department

MEDICINA CLINICA. 2026; 166(1): Nº de citas: 1 [doi:10.1016/j.medcli.2025.107312]

Galnares, MR; Morillo-Verdugo, R; Robustillo-Cortes, MD; Vélez-Diaz-Pallarés, M; Albir, MJC; Vega, BP; López, LL; Ventura, LM; Villanueva, MF; Atorrasagasti, OM; Gutiérrez, E.

Impact of a CMO-Based Pharmaceutical Care Model on 3-HIT Criteria in Older People Living with HIV: The DIS3HIT Project

Patient Preference and Adherence. 2026; 20: 1-12 [doi:10.2147/PPA.S569460]

León-Tarife, P; Arnalich-Montiel, F; Mingo-Botin, D; de Maria, FD; Stokking, M; Saenz-Madrazo, N; Etxebarria-Ecenarro, J; Arriola-Villalobos, P; de los Bueis, AB; González-Diaz, I.

Self-supervised learning and hybrid deep models for predicting the progression of Fuchs' endothelial corneal dystrophy after cataract surgery

Computer Methods and Programs in Biomedicine. 2026; 273: 109100-109100 [doi:10.1016/j.cmpb.2025.109100]

Climente-Martí, M; García-González, X; Torres-Bondia, FI; Lozano, J; Gómez-Navarro, V.

Cost-effectiveness of non-statin lipid-lowering therapies as an add-on to statins for achieving low-density lipoprotein cholesterol therapeutic targets in very high-risk patients in the Spanish setting

JOURNAL OF MEDICAL ECONOMICS. 2025; 28(1): 1857-1868 [doi:10.1080/13696998.2025.2575456]

Ripa, C; Olariaga, O; Vallinas, S; Sirvent, M; Prado, E; Romero, R; Perez, L; Terroba, P; Hernández, S; Chica, A; Gandara, MJ; Bourgon, L; Ochagavia, M; Tamayo, R; Leunda, L.

OncoNutridos study: Prevalence of disease-related malnutrition according to GLIM criteria in cancer patients in oncohaematology day hospitals

Clinical Nutrition ESPEN. 2025; 70: 666-675 [doi:10.1016/j.clnesp.2025.11.008]

Somoza-Fernandez, B; de Lorenzo-Pinto, A; Escudero-Vilaplana, V; Manrique-Rodriguez, S; Villanueva-Bueno, C; Martin-Barbero, ML; Redondo-Galan, C; Calatayud-Garcia, J; Gonzalez-Ramallo, V; Herranz-Alonso, A; Sanjurjo-Saez, M.

Standardizing hospital pharmacy practice in home hospitalization: results from a multidisciplinary Delphi consensus in Spain

Frontiers in Public Health. 2025; 13: [doi:10.3389/fpubh.2025.1707726]

Jiménez, RMR; Pinto, PH; Domínguez, MC; Bellmunt, A; Vidal-Vilar, N; Soto, MDF; Juste, AD.

Cost-Effectiveness Analysis of Abrocitinib Compared with Dupilumab for Adolescents With Severe Atopic Dermatitis in Spain

Pharmacoeconomics-Open. 2025; 10(1): 209-213 [doi:10.1007/s41669-025-00616-9]

Roncero, C; Sánchez-García, A; Burguet, LC; Moreno, AF; Barbero, MLM; Aguilera-Serrano, C; Dorado, VO; Remacha, JG; Prieto, JR; Pérez-Esteve, C; Vila, MS; Solves, JJM.

Relevant Criteria for Improving Quality of Schizophrenia Spectrum Disorders Treatment: A Delphi Study

Healthcare. 2025; 13(22): [doi:10.3390/healthcare13222847]